|
|
|
Volumn 2, Issue SUPPL. 4, 1997, Pages 71-83
|
|
Issues for the future of antiretroviral therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
DELAVIRDINE;
DIDANOSINE;
FLUCONAZOLE;
INDINAVIR;
ITRACONAZOLE;
KETOCONAZOLE;
LAMIVUDINE;
MICONAZOLE;
NELFINAVIR;
NEVIRAPINE;
ORAL CONTRACEPTIVE AGENT;
PROTEINASE INHIBITOR;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
THEOPHYLLINE;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ANTIVIRAL ACTIVITY;
CHILD;
COST EFFECTIVENESS ANALYSIS;
DEVELOPING COUNTRY;
DRUG INDUCED DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
ORAL DRUG ADMINISTRATION;
PATIENT COMPLIANCE;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
REVIEW;
VIRUS INFECTION;
VIRUS TRANSMISSION;
|
|
EID: 0030869811
PISSN: 13596535
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (45)
|
